Kevin Charles Gorman
Kevin Charles Gorman's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…
Insider buying and selling since 2008
Kevin Charles Gorman bought shares on the open market in 2024, and has not bought since 2024 across 2 companies. Sales in each of the last 12 years.
Kevin Charles Gorman reported 1 open-market purchase and 88 sales since 2008; purchases in 2024.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 8×8 trades |
| 2024 | 1×1 trade | 6×6 trades |
| 2023 | — | 6×6 trades |
| 2022 | — | 4×4 trades |
| 2021 | — | 6×6 trades |
| 2020 | — | 7×7 trades |
| 2019 | — | 7×7 trades |
| 2018 | — | 5×5 trades |
| 2017 | — | 7×7 trades |
| 2016 | — | 3×3 trades |
| 2015 | — | 5×5 trades |
| 2014 | — | 5×5 trades |
| 2011 | — | 1×1 trade |
| 2010 | — | 2×2 trades |
| 2009 | — | 2×2 trades |
| 2008 | — | 14×14 trades |
Insider at 2 companies
- Neurocrine Biosciences NBIX2008–2025 · 0 purchases, 87 sales
- Xencor Inc XNCR2024–2025 · 1 purchase, 1 sale
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Kevin Charles Gorman's trades
Has Kevin Charles Gorman bought shares on the open market?
Kevin Charles Gorman bought shares on the open market in 2024, and has not bought since 2024 across 2 companies. Sales in each of the last 12 years.
When did Kevin Charles Gorman last buy or sell shares?
In SEC filings since 2008: the latest open-market purchase is from 2024; the latest open-market sale is from 2025.
Which companies has Kevin Charles Gorman traded as an insider?
2 companies: Neurocrine Biosciences (NBIX, 2008–2025), Xencor Inc (XNCR, 2024–2025).